Table 2.
Population | Phenytoin | Placebo | Mean Difference | ||||
---|---|---|---|---|---|---|---|
Post Application NRS Score | Mean NRS Difference | ||||||
Mean | 95% CI | Mean | 95% CI | Mean | 95% CI | P-value | |
All patients (N = 12) | 4.3 | 3.5 to 5.1 | 5.2 | 4.4 to 6.0 | 0.9 | 0.4 to 1.4 | 0.003 |
Responders* (N = 6) | 3.0 | 2.5 to 3.5 | 4.3 | 3.8 to 4.8 | 1.3 | 1.1 to 1.8 | < 0.001 |
Non-responders (N = 6) | 5.7 | 5.2 to 6.2 | 6.2 | 5.7 to 6.7 | 0.5 | −0.2 to 1.2 | 0.2 |
% Pain Reduction from Baseline | Mean % Difference | ||||||
Mean | 95% CI | Mean | 95% CI | Mean | 95% CI | P-value | |
All patients (N = 12) | 29 | 13 to 45 | 12 | −2 to 26 | 17 | 6 to 28 | 0.006 |
Responders* (N = 6) | 51 | 40 to 62 | 28 | 15 to 42 | 22 | 13 to 32 | 0.001 |
Non-responders (N = 6) | 8; | −5 to 20 | −4 | −20 to 11 | 12 | −12 to 36 | 0.3 |
Note: *Responder is defined as ≥2 points pain reduction on the NRS as well as ≥1 point difference between the phenytoin 10% cream and the placebo cream applied area in favour of phenytoin 10% cream.
Abbreviations: NRS, 11-point numerical rating scale, CI, confidence interval; N, number of patients.